# Phase 6.5 Adversarial Review Summary

**Paper:** Dose-Response Relationships in LLM Data Curation
**Date:** 2026-08-28
**Status:** CONVERGED

---

## Review Statistics

| Metric | Value |
|--------|-------|
| Total Rounds | 2 |
| FATAL Issues Found | 0 |
| MAJOR Issues Found | 1 |
| MAJOR Issues Fixed | 1 |
| Minor Issues (Human Review) | 0 |
| Convergence Round | R2 |

---

## Round Summary

### Round 1: Accuracy and Engagement

**Personas:** Accuracy Checker, Bored Reviewer, Skeptical Expert

**Findings:**
- All 12 numerical claims verified against ground truth
- Persuasiveness checks passed (abstract compelling, novelty clear)
- 1 MAJOR issue: Mock evaluation caveat insufficiently prominent

**Actions:**
- Added "at proof-of-concept scale" to Abstract
- Added explicit PoC note to Results Section 5.6

### Round 2: Verification and Credibility

**Personas:** Accuracy Checker, Skeptical Expert

**Findings:**
- Cross-verified all claims against Phase 4 validation files (H-E1, H-M1, H-M3, H-C1)
- Baseline comparison methodology verified as fair
- Confidence levels appropriately reflected
- No new issues found

---

## Final Recommendation

**CONDITIONAL_ACCEPT**

The paper has passed adversarial review with the following conditions:
1. All numerical claims verified against ground truth and Phase 4/5 artifacts
2. Limitations appropriately disclosed (mock evaluation, reduced scale)
3. No overclaims detected after R1 revision
4. Persuasiveness criteria met

---

## Artifacts Generated

| Artifact | Path |
|----------|------|
| Final Paper | `paper/06_paper_final.md` |
| R1 Review | `paper/review/065_review_r1.md` |
| R2 Review | `paper/review/065_review_r2.md` |
| Changelog | `paper/review/065_changelog.md` |
| Checkpoint | `paper/review/065_review_checkpoint.yaml` |

---

## Verification Checklist

- [x] All numerical claims match ground truth
- [x] Mock evaluation caveat disclosed in Abstract
- [x] Mock evaluation caveat disclosed in Results
- [x] Limitations section complete
- [x] Baseline comparison methodology fair
- [x] Novelty claims appropriately scoped
- [x] Persuasiveness criteria passed

---

*Generated: 2026-08-28T16:30:00Z*
*Phase 6.5 Adversarial Review Complete*
